ES461918A1 - Un procedimiento para la obtencion de un preparado fomenta- dor de la coagulacion de la sangre a base de plasma sangui- neo humano. - Google Patents
Un procedimiento para la obtencion de un preparado fomenta- dor de la coagulacion de la sangre a base de plasma sangui- neo humano.Info
- Publication number
- ES461918A1 ES461918A1 ES461918A ES461918A ES461918A1 ES 461918 A1 ES461918 A1 ES 461918A1 ES 461918 A ES461918 A ES 461918A ES 461918 A ES461918 A ES 461918A ES 461918 A1 ES461918 A1 ES 461918A1
- Authority
- ES
- Spain
- Prior art keywords
- coagulation
- blood
- feiba
- producing
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
- Y10S530/83—Plasma; serum
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/28—Bound to a nonpeptide drug, nonpeptide label, nonpeptide carrier, or a nonpeptide resin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- External Artificial Organs (AREA)
Abstract
Un procedimiento para la obtención de un preparado fomentador de la coagulación de la sangre a base de plasma sanguíneo humano, que contiene una nueva sustancial coagulante de la sangre, llamada ¿FEIBA¿, caracterizado porque un plasma humano con contenido de iones de citratao se trata, en ausencia de iones de calcio libres, con sustancias inorgánicas insolubles en agua, tensioactivas, tales como gel de sílice o caolina, con lo que se genera la nueva sustancia; a continuación se separan las sustancias insolubles en agua tratándose entonces el sobrante, de la manera conocida, con intercambiadores básicos de iones, tales como sustancias de alto peso molecular que contengan grupos de dietilaminoetilo, con lo que resulta adsorbida la sustancia FEIBA, junto con los factores II-VII-IX-X, que se eluyen y concentran seguidamente.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT640576A AT350726B (de) | 1976-08-30 | 1976-08-30 | Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma |
Publications (1)
Publication Number | Publication Date |
---|---|
ES461918A1 true ES461918A1 (es) | 1978-12-16 |
Family
ID=3585985
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES461918A Expired ES461918A1 (es) | 1976-08-30 | 1977-08-26 | Un procedimiento para la obtencion de un preparado fomenta- dor de la coagulacion de la sangre a base de plasma sangui- neo humano. |
Country Status (17)
Country | Link |
---|---|
US (1) | US4160025A (es) |
AR (1) | AR213861A1 (es) |
AT (1) | AT350726B (es) |
BE (1) | BE858031A (es) |
CA (1) | CA1079191A (es) |
CH (1) | CH635747A5 (es) |
DE (1) | DE2734821C3 (es) |
DK (1) | DK151932C (es) |
ES (1) | ES461918A1 (es) |
FI (1) | FI57421C (es) |
FR (1) | FR2362633A1 (es) |
GB (1) | GB1554051A (es) |
HU (1) | HU180816B (es) |
LU (1) | LU78024A1 (es) |
NL (1) | NL170922C (es) |
NO (1) | NO148142C (es) |
SE (1) | SE443511B (es) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2902158A1 (de) * | 1979-01-20 | 1980-07-31 | Biotest Serum Institut Gmbh | Verfahren zur herstellung von fibrinogen, einem die gerinnungsfaktoren ii, vii, ix und x enthaltenden prothrombinkomplex, antithrombin iii und einer loesung von lagerstabilen serumproteinen |
US4286056A (en) * | 1980-01-28 | 1981-08-25 | Baxter Travenol Laboratories, Inc. | Method for making therapeutic enzyme compositions |
JPH0686385B2 (ja) * | 1980-01-28 | 1994-11-02 | バクスタ−、インタ−ナショナル、インコ−ポレイテッド | 活性プロトロンビン複合体組成物およびその製造方法 |
US4287180A (en) * | 1980-01-28 | 1981-09-01 | Baxter Travenol Laboratories, Inc. | Method for treating blood clotting factor inhibitors |
DE3176491D1 (en) * | 1980-03-05 | 1987-11-26 | Miles Lab | Pasteurized therapeutically active protein compositions |
EP0041174B1 (en) * | 1980-05-27 | 1985-09-11 | Miles Laboratories, Inc. | Blood coagulation promoting product and process of preparing same |
US4404132A (en) * | 1980-05-27 | 1983-09-13 | Cutter Laboratories, Inc. | Blood coagulation promoting product |
US4391746A (en) * | 1980-05-27 | 1983-07-05 | Cutter Laboratories, Inc. | Blood-coagulation-promoting products and methods of preparing them |
US4364861A (en) * | 1980-05-27 | 1982-12-21 | Cutter Laboratories, Inc. | Blood-coagulation-promoting products and methods of preparing them |
US4361510A (en) * | 1980-05-27 | 1982-11-30 | Cutter Laboratories, Inc. | Blood coagulation promoting product |
AT368883B (de) * | 1980-07-22 | 1982-11-25 | Immuno Ag | Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen |
DE3101752A1 (de) * | 1981-01-21 | 1982-08-26 | Behringwerke Ag, 3550 Marburg | "verfahren zur reinigung der blutgerinnungsfaktoren ii, vii, ix und/oder x und danach hergestellte praeparationen" |
US4382083A (en) * | 1981-06-25 | 1983-05-03 | Baxter Travenol Laboratories, Inc. | Therapeutic method for treating blood-clotting defects with factor VIIa |
US4479938A (en) * | 1981-06-25 | 1984-10-30 | Baxter Travenol Laboratories, Inc. | Therapeutic composition containing factor VIIa |
JPS5866054A (ja) * | 1981-10-14 | 1983-04-20 | Sekisui Chem Co Ltd | 血液検査用容器 |
JPS58105064A (ja) * | 1981-12-17 | 1983-06-22 | Sekisui Chem Co Ltd | 血液凝固促進剤 |
AT389815B (de) * | 1984-03-09 | 1990-02-12 | Immuno Ag | Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten |
DE3625090A1 (de) * | 1986-07-24 | 1988-01-28 | Behringwerke Ag | Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung |
US5118614A (en) * | 1988-01-18 | 1992-06-02 | Tessek Sdruzeni Praha | Concentrates of coagulation factors ii, vii, ix and x, method of their preparation and use |
AT402891B (de) * | 1991-06-20 | 1997-09-25 | Immuno Ag | Verfahren zur herstellung eines inaktivierten blutproduktes |
AT398079B (de) * | 1991-11-04 | 1994-09-26 | Immuno Ag | Präparation mit thrombinaktivität sowie verfahren zu ihrer herstellung |
AT399818B (de) * | 1992-04-24 | 1995-07-25 | Immuno Ag | Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation |
JP3133338B2 (ja) * | 1992-12-16 | 2001-02-05 | イムノ・アクチエンゲゼルシャフト | ウイルス的に安全な生物学的組成物の調製方法 |
DE4320294A1 (de) * | 1993-06-18 | 1994-12-22 | Immuno Ag | Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen |
US5677162A (en) * | 1995-05-01 | 1997-10-14 | New York Blood Center, Inc. | Method for activating prothrombin to thrombin |
DE19531637A1 (de) * | 1995-08-28 | 1997-03-06 | Immuno Ag | Pharmazeutische Zusammensetzung zur Behandlung von Blutgerinnungsstörugnen, Verfahren zur Herstellung derselben und deren Verwendung |
DK0796623T3 (da) * | 1996-03-20 | 2005-08-01 | Baxter Ag | Farmaceutisk præparat til behandling af blodkoagulationslidelser |
AT405485B (de) | 1997-05-28 | 1999-08-25 | Immuno Ag | Eine das vwf-propeptid enthaltende pharmazeutische präparation |
AT407484B (de) * | 1997-11-12 | 2001-03-26 | Bio Prod & Bio Eng Ag | Arzneimittel zur förderung der wundheilung |
EP1528930B1 (de) * | 2002-07-23 | 2009-04-15 | Bio & Bio Licensing SA | Thrombingenerierfähige und thrombinhaltige pharmazeutische wirkstoffzubereitungen und arzneimittel |
RS20050051A (en) * | 2002-07-23 | 2007-06-04 | Bio-Products & Bio Engineering Ag., | Pharmaceutical active ingredient preparation and medicaments that contain thrombin or have a thrombin-generating capacity |
EP2305289A1 (en) | 2009-09-16 | 2011-04-06 | Bio-Products & Bio-Engineering Aktiengesellschaft | Medicinal products for the treatment of blood coagulation disorders |
IS2809B (is) * | 2011-03-08 | 2012-10-15 | Haskoli Islands | Blóðstorkumæling |
RU2648517C1 (ru) * | 2017-06-23 | 2018-03-26 | Федеральное государственное бюджетное учреждение Гематологический научный центр Министерства здравоохранения Российской Федерации (ФГБУ ГНЦ Минздрава России) | Способ получения лиофилизированного препарата активированного протромбинового комплекса, обладающего фактор viii-шунтирующей активностью |
WO2024012853A1 (de) | 2022-07-12 | 2024-01-18 | Biomedizinische Forschung & Bio-Produkte AG | Arzneimittel zur förderung der hämostase |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2262520C3 (de) * | 1972-12-20 | 1987-02-12 | Miles Laboratories, Inc., Elkhart, Ind. | Verfahren zur Herstellung eines lyophilisierten, lagerfähigen Konzentrats aus menschlichem Plasma |
DE2459291C3 (de) * | 1974-12-14 | 1981-06-04 | Biotest-Serum-Institut Gmbh, 6000 Frankfurt | Verfahren zur Herstellung eines antihämophiles Globulin A enthaltenden Konzentrats neben einem Prothrombin- Komplex und einer Lösung von lagerstabilen Serumproteinen |
US3998946A (en) * | 1975-04-23 | 1976-12-21 | The Regents Of The University Of Minnesota | Fibrinogen-free plasminogen-plasmin-free plasma and method of preparing and using same |
DD121793A1 (es) * | 1975-07-17 | 1976-08-20 | ||
US4027013A (en) * | 1976-01-22 | 1977-05-31 | William L. Wilson | Clottable fibrinogen free factor VIII and albumin product and process |
-
1976
- 1976-08-30 AT AT640576A patent/AT350726B/de not_active IP Right Cessation
-
1977
- 1977-07-08 SE SE7707992A patent/SE443511B/xx not_active IP Right Cessation
- 1977-08-02 DE DE2734821A patent/DE2734821C3/de not_active Expired
- 1977-08-03 GB GB32578/77A patent/GB1554051A/en not_active Expired
- 1977-08-08 US US05/822,679 patent/US4160025A/en not_active Expired - Lifetime
- 1977-08-10 FI FI772408A patent/FI57421C/fi not_active IP Right Cessation
- 1977-08-11 AR AR268769A patent/AR213861A1/es active
- 1977-08-11 NL NLAANVRAGE7708872,A patent/NL170922C/xx not_active IP Right Cessation
- 1977-08-19 CH CH1022077A patent/CH635747A5/de not_active IP Right Cessation
- 1977-08-19 CA CA285,026A patent/CA1079191A/en not_active Expired
- 1977-08-22 FR FR7725597A patent/FR2362633A1/fr active Granted
- 1977-08-23 BE BE180368A patent/BE858031A/xx not_active IP Right Cessation
- 1977-08-25 LU LU78024A patent/LU78024A1/xx unknown
- 1977-08-26 HU HU77IU288A patent/HU180816B/hu unknown
- 1977-08-26 ES ES461918A patent/ES461918A1/es not_active Expired
- 1977-08-29 NO NO772978A patent/NO148142C/no unknown
- 1977-08-30 DK DK384577A patent/DK151932C/da not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA1079191A (en) | 1980-06-10 |
FI57421B (fi) | 1980-04-30 |
FR2362633A1 (fr) | 1978-03-24 |
FR2362633B1 (es) | 1981-06-12 |
LU78024A1 (es) | 1978-01-11 |
NL170922C (nl) | 1983-01-17 |
CH635747A5 (de) | 1983-04-29 |
DK151932C (da) | 1988-06-20 |
US4160025A (en) | 1979-07-03 |
AT350726B (de) | 1979-06-11 |
HU180816B (en) | 1983-04-29 |
NL170922B (nl) | 1982-08-16 |
NL7708872A (nl) | 1978-03-02 |
NO772978L (no) | 1978-03-01 |
DE2734821B2 (de) | 1980-11-06 |
DE2734821C3 (de) | 1985-03-14 |
NO148142B (no) | 1983-05-09 |
DE2734821A1 (de) | 1978-03-02 |
ATA640576A (de) | 1978-11-15 |
SE443511B (sv) | 1986-03-03 |
GB1554051A (en) | 1979-10-17 |
SE7707992L (sv) | 1978-03-01 |
BE858031A (fr) | 1977-12-16 |
AR213861A1 (es) | 1979-03-30 |
FI57421C (fi) | 1980-08-11 |
DK151932B (da) | 1988-01-18 |
DK384577A (da) | 1978-03-01 |
FI772408A (fi) | 1978-03-01 |
NO148142C (no) | 1983-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES461918A1 (es) | Un procedimiento para la obtencion de un preparado fomenta- dor de la coagulacion de la sangre a base de plasma sangui- neo humano. | |
GB2181348B (en) | Controlled release metoprolol preparations | |
MY100729A (en) | Food process | |
MY109990A (en) | Microfluidised particles of atovaquone and pharmaceutical preparation thereof | |
JPS51145474A (en) | A blood dialysis membrane with outstanding dialysis performance and a process for producing it | |
HUT43091A (en) | Process for producing mannosyl-aglycon of antibiotic a 40926 | |
ES8203609A1 (es) | Procedimiento de obtencion de preparados promotores de la coagulacion sanguinea | |
DE3478749D1 (en) | Covalently bound heparin - antithrombin-iii complex, method for its preparation and its use for treating thromboembolism | |
DE2960213D1 (en) | Process for the preparation of saturated aliphatic, cycloaliphatic and araliphatic aldehydes | |
DE3268159D1 (en) | Medicaments based on algae, and formulations thereof | |
ES8704962A1 (es) | Un procedimiento para preparar 1b-d-ribofuranosil, 1-2-4-triazol-3-carboxamida. | |
ES8404693A1 (es) | Procedimiento de preparacion de nuevos amino-14 esteroides. | |
HUT36783A (en) | Process for preparing 1,7-diphenyl-3-methyl-aza-7-cyano-8-methyl-nonane | |
JPS5234840A (en) | Sanitary interior fitting for shoes and production method of same | |
JPS5328509A (en) | Treating method for increasing high temperature strength of pure titanium material | |
HU900525D0 (en) | Process for the production of medical preparations for treating endotoxinemy | |
JPS5224188A (en) | Treatment of aluminum-sludge including phosphorus | |
JPS5265973A (en) | Process for treating water containing phosphate and sulfate ions | |
JPS51134085A (en) | Method to manufacture the semiconductor unit | |
SU1630043A1 (ru) | Плазмозамещающий раствор для лечения шока "мафусол" | |
JPS524637A (en) | Dental correcting fittings made of polyurethane resin and manufacturin g method | |
JPS5237153A (en) | Method of transplantation of hairs to human skin | |
JPS5239573A (en) | Process for destroying the texture of the animal fibrous material by s welling and softening | |
JPS51136359A (en) | Compound waste water treating material | |
JPS5388390A (en) | Preparation of fibrinolytic solid surface |